On January 24, 2023 Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, reported it will participate in the following upcoming investor and industry conferences (Press release, Synlogic, JAN 24, 2023, View Source [SID1234626551]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BIO CEO & Investor Conference: Molly Harper, Chief Business Officer, and Michael Jensen, Chief Financial Officer, will participate in-person and virtually at the BIO CEO & Investor Conference 2023 being held February 6-9, 2023, in New York City. Ms. Harper will present in-person at 4:15 p.m. ET on Monday, February 6. In addition, an on-demand video presentation will be available for conference participants during the event, and for approximately 30 days after the event.
SVB Securities Global Biopharma Conference: The Synlogic management team will participate in the SVB Securities Global Biopharma Conference 2023, being held virtually February 14-16, 2023. Aoife Brennan, M.B. Ch.B., Synlogic President and Chief Executive Officer, will present virtually at 12 p.m. ET on Thursday, February 16. Register for her presentation here.
Recorded presentations, if available, can be found on the Events section of the Synlogic website. Archived versions of webcasts will also be available after the presentations on the Synlogic website.